Gökhan AYTEKİN, Fatih ÇÖLKESEN, Eray YILDIZ, Şevket ARSLAN, İsmail BALOĞLU, Kültigin TÜRKMEN

Nephrological factors may cause kidney dysfunction in patients with common variable immunodeficiency

Background/aim: Common variable immunodeficiency (CVID) is a heterogeneous primary deficiency characterized by hypogammaglobulinemia, recurrent infections, an increased risk of autoimmune disease, malignancy, and chronic inflammation. Proteinuria is one of the most important prognostic factors causing progression in kidney disease. Proteinuria causes tubulotoxicity, activates inflammatory markers that cause fibrosis, and consequently nephropathy progression. The data is scant in the literature regarding the inflammation and nephropathy in CVID. Hence, in the present study, we aimed to investigate the relationship between tubular dysfunction, proteinuria, and inflammation in patients with CVID. Materials and methods: This was a cross-sectional study involving 27 patients with CVID (15 females, 12 males; mean age, 39.88 ± 13.47 years) and 18 control subjects (10 females, 8 males; mean age, 33.83 ± 7.97 years). Patients were evaluated for kidney functions including glomerular filtration rate, fractional excretion of sodium, metabolic acidosis, serum/urine anion gap, 24-h urine proteinuria and, were grouped in terms of proteinuria. Blood samples obtained from the patients with CVID were taken into 2 mL EDTA tube to evaluate peripheral NK cell subgroups according to CD56 and CD16 expression and CD3, CD4, CD 8 expression to determine subtypes T cells. These cells were evaluated by flow cytometry technique. Results: Urinary density, fractional excretion of sodium, proteinuria, and metabolic acidosis are found to be higher in patients with CVID when compared to healthy controls. In the bivariate correlation analysis, proteinuria was positively correlated with age (r = 0.496, p = < 0.001), CD8+T cells percentage (r = 0.427, p = 0.02). Albumin, CRP, and CD8+T cell percentage were found to be independent variables of proteinuria. Conclusion: Increased chronic ongoing inflammation was found to be associated with proteinuria in patients with CVID. Hence, in routine outpatient clinics, proteinuria should not be overlooked in this group of patients.Key words: Chronic inflammation, proteinuria, common variable immunodeficiency

PDF

___

1. Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of Allergy and Clinical Immunology 2015; 136 (5): 1186-1205. doi: 10.1016/j. jaci.2015.04.049
2. Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. Journal of Clinical Immunology 2018; 38 (1): 129-143. doi: 10.1007/s10875-017-0465-8
3. Luis-Rodriguez D, Martinez-Castelao A, Gorriz JL, DeAlvaro F, Navarro-Gonzalez JF. Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World Journal of Diabetes 2012; 3 (1): 7-18. doi: 10.4239/wjd.v3.i1.7
4. Turkmen K. Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the four horsemen of the apocalypse. International Urology and Nephrology 2017; 49 (5): 837-844. doi: 10.1007/ s11255-016-1488-4
5. Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Annals of Internal Medicine 2003; 139 (4): 244-252. doi: 10.7326/0003- 4819-139-4-200308190-00006
6. Lea J, Greene T, Hebert L, Lipkowitz M, Massry S et al. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Archives of Internal Medicine 2005; 165 (8): 947-953. doi: 10.1001/ archinte.165.8.947
7. Shiigai T, Shichiri M. Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease. The American Journal of Kidney Diseases 2001; 37 (3): 477- 483. doi: 10.1053/ajkd.2001.22069
8. Emmet M, Hoorn EJ. Serum anion gap in conditions other than metabolic acidosis. Up To Date. April 13, 2020.
9. Emmet M, Palmer BF. Urine anion and osmolal gaps in metabolic acidosis. Up To Date. March 12, 2019.
10. Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC et al. Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. 2012; 2 (2): 139-274.
11. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. The Quarterly Journal of Medicine 1993; 86 (1): 31-42.
12. Fakhouri F, Robino C, Lemaire M, Droz D, Noel LH et al. Granulomatous renal disease in a patient with common variable immunodeficiency. The American Journal of Kidney Diseases 2001; 38 (2): E7. doi: 10.1053/ajkd.2001.26117
13. Meyer A, Lachmann HJ, Webster AD, Burns A, Thway K. Hypercalcemia in a patient with common variable immunodeficiency and renal granulomas. The American Journal of Kidney Diseases 2005; 45 (5): e90-93. doi: 10.1053/j. ajkd.2005.02.023
14. Aydin Z, Gursu M, Ozturk S, Kilicaslan I, Kazancioglu R. A case of primary immune deficiency presenting with nephrotic syndrome. NDT Plus 2010; 3 (5): 456-458. doi: 10.1093/ ndtplus/sfq083
15. Endo LM, Giannobile JV, Dobbs AK, Foote JB, Szymanska E et al. Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin. The Journal of Investigational Allergology and Clinical Immunology 2011; 21 (5): 405-409.
16. Kadiroglu AK, Yildirim Y, Yilmaz Z, Kayabasi H, Avci Y et al. A rare cause of secondary amyloidosis: common variable immunodeficiency disease. Case Reports in Nephrology and Dialysis 2012; 2012: 860208. doi: 10.1155/2012/860208
17. Tsuji K, Uchida HA, Ono T, Inoue T, Shinagawa K et al. A case of focal segmental glomerulosclerosis in an adult patient with hypogammaglobulinemia superimposed on membranoproliferative glomerulonephritis in childhood. BMC Nephrology 2012; 13: 46. doi: 10.1186/1471-2369-13-46
18. Capistrano GG, Meneses GC, De Oliveira Neves FM, De Almeida Leitao R, Martins AMC et al. Renal evaluation in common variable immunodeficiency. Journal of Immunology Research. 2018; 2018: 5841031. doi: 10.1155/2018/5841031
19. Sarkar S, Mondal R, Nandi M, Ghosh P. Chronic tubulointerstitial nephritis in common variable immunodeficiency: a rare association. Saudi Journal of Kidney Diseases and Transplantation 2014; 25 (2): 394-397. doi: 10.4103/1319- 2442.128582
20. Jorgensen SF, Fevang B, Aukrust P. Autoimmunity and inflammation in CVID: a possible crosstalk between immune activation, gut microbiota, and epigenetic modifications. The Journal of Clinical Immunology 2019; 39 (1): 30-36. doi: 10.1007/s10875-018-0574-z
21. Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I et al. Serum albumin: a late-reacting negative acute-phase protein in clinically evident inflammation in dialysis patients. Nephrology Dialysis Transplantation 2005; 20 (3): 658-659; author reply 59-60. doi: 10.1093/ndt/gfh663
22. Wong DWL, Yiu WH, Chan KW, Li Y, Li B et al. Activated renal tubular Wnt/beta-catenin signaling triggers renal inflammation during overload proteinuria. Kidney International 2018; 93 (6): 1367-1383. doi: 10.1016/j.kint.2017.12.017
23. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003; 362 (9384): 629-639.
24. Turkmen K, Anil M, Solak Y, Atalay H, Esen H et al. A hepatitis C-positive patient with new onset of nephrotic syndrome and systemic amyloidosis secondary to common variable immunodeficiency. Annals of Saudi Medicine 2010; 30 (5): 401-403. doi: 10.4103/0256-4947.67085
25. Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H. The role of the T cell in autoimmune inflammation. Arthritis Research and Therapy 2005; 7 Suppl 2: S4-14. doi: 10.1186/ar1703
26. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Annals of Laboratory Medicine 2019; 39 (4): 345-357. doi: 10.3343/alm.2019.39.4.345
27. Cukic V. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with NSLC. Materia Socio-Medica 2016; 28 (5): 378-381. doi: 10.5455/msm.2016.28.378-381
28. Hammad M, Shehata OZ, Abdel-Latif SM, El-Din AMM. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behcet’s disease: which and when to use? Clinical Rheumatology 2018; 37 (10): 2811-2817. doi: 10.1007/s10067- 018-4194-z
29. Mazza MG, Lucchi S, Tringali AGM, Rossetti A, Botti ER et al. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Progress in NeuroPsychopharmacology & Biological Psychiatry 2018; 84 (Pt A): 229-236. doi: 10.1016/j.pnpbp.2018.03.012
30. Omran A, Maaroof A, Saleh MH, Abdelwahab A. Salivary C-reactive protein, mean platelet volume and neutrophil lymphocyte ratio as diagnostic markers for neonatal sepsis. Jornal de Pediatria 2018; 94 (1): 82-87. doi: 10.1016/j. jped.2017.03.006
31. Ucar R, Arslan S, Turkmen K, Caliskaner AZ. Accelerated atherosclerosis in patients with common variable immunodeficiency: is it overlooked or absent? Medical Hypotheses 2015; 85 (4): 485-487. doi: 10.1016/j. mehy.2015.07.002
32. Patuzzo G, Barbieri A, Tinazzi E, Veneri D, Argentino G et al. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmunity Reviews 2016; 15 (9): 877-882. doi: 10.1016/j.autrev.2016.07.011
33. Lacombe V, Lozac’h P, Orvain C, Lavigne C, Miot C et al. Treatment of ITP and AIHA in CVID: a systematic literature review. Revue de Médecine Interne 2019; 40 (8): 491-500. doi: 10.1016/j.revmed.2019.02.006
34. Aytekin G, Çölkesen F, Yıldız E, Arslan. Risk factors of bronchiectasis in adult patients with common variable immunodeficiency. Asthma Allergy Immunology 2019; 17 (3): 160-165. doi: 10.21911/aai.502
35. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. The Journal of Allergy and Clinical Immunology 2002; 109 (6): 1001-1004. doi: 10.1067/mai.2002.124999
36. Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. The Journal of Allergy and Clinical Immunology 1999; 104 (5): 1031-1036. doi: 10.1016/ s0091-6749(99)70085-0
37. De Gracia J, Vendrell M, Alvarez A, Pallisa E, Rodrigo MJ et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. International Immunopharmacology 2004; 4 (6): 745-753. doi: 10.1016/j. intimp.2004.02.011